Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)

PURPOSE: To investigate trends in SGLT2i and GLP-1RA use in Australia in the era of increased evidence of their cardiovascular benefits. METHODS: We used national dispensing claims for a 10% random sample of Australians to estimate the number of prevalent and new users (no dispensing in the prior ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jialing, Pearson, Sallie-Anne, Greenfield, Jerry R., Park, Kyeong Hye, Havard, Alys, Brieger, David, Day, Richard O., Falster, Michael O., de Oliveira Costa, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427543/
https://www.ncbi.nlm.nih.gov/pubmed/37449993
http://dx.doi.org/10.1007/s00228-023-03539-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427543/
https://www.ncbi.nlm.nih.gov/pubmed/37449993
http://dx.doi.org/10.1007/s00228-023-03539-8

Ejemplares similares